Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions

M Arbyn, J Roelens, C Simoens… - Cochrane database …, 2013 - cochranelibrary.com
Background Atypical squamous cells of undetermined significance (ASCUS) and low‐grade
squamous intra‐epithelial lesions (LSIL) are minor lesions of the cervical epithelium …

Histology of cervical intraepithelial neoplasia and the role of biomarkers

CM Martin, JJ O'Leary - Best practice & research Clinical obstetrics & …, 2011 - Elsevier
Accurate histological grading of cervical intraepithelial neoplasia (CIN) lesions is important
for clinical management of patients, because CIN1 and CIN2 and 3 lesions are treated …

Predictive value of p16/Ki-67 immunocytochemistry for triage of women with abnormal Papanicolaou test in cervical cancer screening: a systematic review and meta …

CC Chen, LW Huang, CH Bai, CC Lee - Annals of Saudi medicine, 2016 - annsaudimed.net
BACKGROUND: The Papanicolaou (Pap) test is one screening strategy used to prevent
cervical cancer in developed countries. The p16/Ki-67 immunocytochemistry is a triage test …

Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test

A Mitra, C Fotopoulou… - Cochrane Database …, 2017 - cochranelibrary.com
Background A significant number of women are diagnosed with minor cytological
abnormalities on cervical screening. Many authorities recommend surveillance as …

Influence of Human Papillomavirus Infection on the Natural History of Cervical Intraepithelial Neoplasia 1: A Meta‐Analysis

M Liu, X Yan, M Zhang, X Li, S Li… - BioMed research …, 2017 - Wiley Online Library
Objective. To provide a scientific basis for the prevention and treatment of cervical
intraepithelial neoplasia grade 1 (CIN1). This study evaluated the impact of human …

Biospectroscopy insights into the multi-stage process of cervical cancer development: probing for spectral biomarkers in cytology to distinguish grades

NC Purandare, II Patel, J Trevisan, N Bolger… - Analyst, 2013 - pubs.rsc.org
Cervical cancer screening programmes have greatly reduced the burden associated with
this disease. However, conventional cervical cytology screening still lacks sensitivity and …

Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years

Y Jayasinghe, C Rangiah, A Gorelik, G Ogilvie… - Journal of Clinical …, 2016 - Elsevier
Abstract Background Revised Australian guidelines have been announced under the
Renew® program to commence screening at 25 years of age with HPV testing in 5-yearly …

Exploiting biospectroscopy as a novel screening tool for cervical cancer: Towards a framework to validate its accuracy in a routine clinical setting

NC Purandare, J Trevisan, II Patel, K Gajjar… - Bioanalysis, 2013 - Taylor & Francis
Biospectroscopy is an emerging field that harnesses the platform of physical sciences with
computational analysis in order to shed novel insights on biological questions. An area …

Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: systematic reviews and economic evaluation

M Peron, A Llewellyn, T Moe-Byrne… - Health technology …, 2018 - eprints.whiterose.ac.uk
BACKGROUND: Dynamic Spectral Imaging System (DySIS) map (DySIS Medical Ltd,
Edinburgh, UK) and ZedScan (Zilico Limited, Manchester, UK) can be used adjunctively with …

High-risk human papillomavirus DNA test: could it be useful in low-grade cervical lesion triage? Five-year follow-up

C Saccardi, S Gizzo, M Noventa, O Anis… - Reproductive …, 2014 - journals.sagepub.com
We conducted a retrospective, observational study in order to evaluate the role of high-risk
human papillomavirus (hrHPV)-DNA test in patients with first diagnosis of low-grade …